Entering text into the input field will update the search result below

Genzyme (GENZ +2.1%) is unexpectedly softening in its resistance to Sanofi-Aventis' (SNY +0.5%)...

Dec. 21, 2010 1:11 PM ETSanofi (SNY) StockJNJ, PFE, MRK, SNYBy: Eli Hoffmann, SA News Editor
Genzyme (GENZ +2.1%) is unexpectedly softening in its resistance to Sanofi-Aventis' (SNY +0.5%) courtship, apparently after being rebuffed in reaching out to other possible buyers including Pfizer (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and Merck (NYSE:MRK). Currently under discussion: a CVR that would give Genzyme upside if leukemia drug Campath proves effective against MS.

Recommended For You

More Trending News

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi